Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI), and we look forward to the next stage of our strategic partnership, as we move closer towards the development and launch of our next generation of stem cell-based healthcare and wellness products.
Comments